SCHEMBL5753071

SCHEMBL5753071

O=C(O)c1ccc2c(c1)OC(F)(F)C(F)(F)O2

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.52
MAPK1 P28482 1/20 0.52
CTNNB1 P35222 3/20 0.51
WNT3A P56704 3/20 0.51
MRGPRX4 Q96LA9 1/20 0.46
SMYD3 Q9H7B4 2/20 0.44
ALOX5 P09917 1/20 0.44
SRD5A2 P31213 1/20 0.42
TSHR P16473 3/20 0.41
TP53 P04637 1/20 0.41
KDM4E B2RXH2 2/20 0.41
GAA P10253 2/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
POLB P06746 1/20 0.41
MAPT P10636 1/20 0.41
CA4 P22748 1/20 0.41
CA6 P23280 1/20 0.41
PTGS2 P35354 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL351400 0.89 CTNNB1 (0.64) ALDH1A1MAPK1CTNNB1WNT3AMRGPRX4
SCHEMBL18641649 0.87 CTNNB1 (0.67) ALDH1A1MAPK1CTNNB1WNT3AMRGPRX4
SCHEMBL5503013 0.86 CTNNB1 (0.49) ALDH1A1MAPK1CTNNB1WNT3AMRGPRX4
SCHEMBL15104920 0.83 TSHR (0.53) CTNNB1WNT3ASMYD3TSHRKIF11
SCHEMBL31085181 0.83 KDM4E (0.49) ALDH1A1CTNNB1WNT3ASMYD3KDM4E
SCHEMBL1907961 0.83 KDM4E (0.49) ALDH1A1CTNNB1WNT3ASMYD3KDM4E
SCHEMBL3255990 0.81 ALDH1A1 (0.52) ALDH1A1MAPK1CTNNB1WNT3AMRGPRX4
SCHEMBL21674399 0.81 ALDH1A1 (0.52) ALDH1A1MAPK1CTNNB1WNT3AMRGPRX4
SCHEMBL2647988 0.80 CTNNB1 (0.55) CTNNB1WNT3ASMYD3
SCHEMBL758294 0.79 KDM4E (0.47) ALDH1A1MAPK1CTNNB1WNT3ASMYD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6982348-B2 Aminoethanol derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-01-03 US disclosed
US-20040127574-A1 Aminoethanol derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-07-01 US disclosed
EP-1362846-A1 AMINOETHANOL DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-11-19 EP disclosed
WO-1996022280-A1 N-SUBSTITUTED 1-ACYLAMINOALKYL PIPERIDINES FOR TREATMENT OF CEREBRAL DISORDERS AND DEPRESSIONS BAYER AKTIENGESELLSCHAFT (DE) 1996-07-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040127574-A1 Aminoethanol derivatives CETP, LCAT, MTTP ALDH1A1 783/4885MAPK1 2140/4885CTNNB1 1000/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.